Literature DB >> 17880768

Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.

A V Marzano1, A Frezzolini, M Caproni, A Parodi, D Fanoni, P Quaglino, V Girgenti, M La Placa, P Fabbri, R Caputo, E Berti.   

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are considered to be severity variants of the same disease, which is almost always associated with drug intake. In contrast, erythema multiforme (EM) is a disorder regarded as only rarely caused by drugs. Keratinocyte apoptosis has been shown to play an important part in the pathogenesis of SJS and TEN, whilst its role in EM remains controversial. To determine the expression of apoptosis-associated molecules Fas, Fas ligand (FasL), Bcl-2 and Bax in the above disorders, an immunohistochemical analysis was performed. We studied both lesional skin from thirty patients having drug-induced EM and 5 cases classified within the SJS/TEN spec nottrum and normal skin samples. We found a keratinocyte overexpression of Fas antigen, an important molecule mediating apoptosis, not only in SJS and TEN but also in EM. Another noteworthy finding was the strong expression of Bcl-2, a protein known as blocking apoptosis, along the basal layer and in the dermal infiltrate both in SJS/TEN and in EM. Taken together, these findings suggest that Fas-dependent keratinocyte apoptosis may play a part in the pathogenesis of both SJS/TEN and EM. Fas-mediated cell death may be partially suppressed by the Bcl-2 protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880768     DOI: 10.1177/039463200702000313

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  4 in total

1.  Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome.

Authors:  A V Marzano; D Fanoni; E Antiga; P Quaglino; M Caproni; C Crosti; P L Meroni; M Cugno
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

3.  Toxic epidermal necrolysis induced by lansoprazole.

Authors:  Tainá Scalfoni Fracaroli; Ludmilla Queirós Miranda; João Luz Sodré; Mário Chaves; Alexandre Gripp
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

4.  Stevens-Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database.

Authors:  Bernardo Sousa-Pinto; Luís Araújo; Alberto Freitas; Osvaldo Correia; Luís Delgado
Journal:  Clin Transl Allergy       Date:  2018-01-22       Impact factor: 5.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.